Ann Breen

642 total citations
10 papers, 507 citations indexed

About

Ann Breen is a scholar working on Molecular Biology, Organic Chemistry and Infectious Diseases. According to data from OpenAlex, Ann Breen has authored 10 papers receiving a total of 507 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Organic Chemistry and 2 papers in Infectious Diseases. Recurrent topics in Ann Breen's work include Carbohydrate Chemistry and Synthesis (2 papers), Receptor Mechanisms and Signaling (2 papers) and Neuropeptides and Animal Physiology (2 papers). Ann Breen is often cited by papers focused on Carbohydrate Chemistry and Synthesis (2 papers), Receptor Mechanisms and Signaling (2 papers) and Neuropeptides and Animal Physiology (2 papers). Ann Breen collaborates with scholars based in United States and United Kingdom. Ann Breen's co-authors include Ashok D. Patil, Alan J. Freyer, Drake S. Eggleston, R. Curtis Haltiwanger, Mark F. Bean, Paul B. Taylor, Mary Jo Caranfa, Charles Norris, Randall K. Johnson and Richard M. Keenan and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Natural Products and Bioorganic & Medicinal Chemistry Letters.

In The Last Decade

Ann Breen

10 papers receiving 466 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ann Breen United States 8 247 144 119 114 33 10 507
Kimio Kawano Japan 14 184 0.7× 258 1.8× 200 1.7× 55 0.5× 17 0.5× 25 508
Ya‐Ping Sun China 16 619 2.5× 137 1.0× 205 1.7× 65 0.6× 9 0.3× 27 893
A. Belinda Alvarado United States 8 92 0.4× 163 1.1× 162 1.4× 22 0.2× 7 0.2× 8 360
YASUYUKI TAKAMATSU United States 9 209 0.8× 134 0.9× 198 1.7× 75 0.7× 30 0.9× 13 398
Huashi Guan China 13 89 0.4× 141 1.0× 144 1.2× 49 0.4× 7 0.2× 28 387
Richard P. Hodge United States 11 65 0.3× 52 0.4× 220 1.8× 30 0.3× 27 0.8× 15 355
Imbi Truumees United States 15 212 0.9× 295 2.0× 152 1.3× 47 0.4× 20 0.6× 22 488
Hai Zhu China 11 179 0.7× 260 1.8× 150 1.3× 115 1.0× 12 0.4× 26 543
Alexandre Orsato Brazil 11 156 0.6× 56 0.4× 172 1.4× 47 0.4× 14 0.4× 28 381

Countries citing papers authored by Ann Breen

Since Specialization
Citations

This map shows the geographic impact of Ann Breen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann Breen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann Breen more than expected).

Fields of papers citing papers by Ann Breen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ann Breen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann Breen. The network helps show where Ann Breen may publish in the future.

Co-authorship network of co-authors of Ann Breen

This figure shows the co-authorship network connecting the top 25 collaborators of Ann Breen. A scholar is included among the top collaborators of Ann Breen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ann Breen. Ann Breen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Dhanak, Dashyant, Richard M. Keenan, George Burton, et al.. (1998). Benzothiopyran-4-one based reversible inhibitors of the human cytomegalovirus (HCMV) protease. Bioorganic & Medicinal Chemistry Letters. 8(24). 3677–3682. 42 indexed citations
2.
DAINES, R. A., Kelvin Sham, William D. Kingsbury, et al.. (1998). ChemInform Abstract: Quinine Analogues as Non‐Peptide Calcitonin Gene‐Related Peptide (CGRP) Receptor Antagonists.. ChemInform. 29(6). 2 indexed citations
3.
Patil, Ashok D., Alan J. Freyer, Drake S. Eggleston, et al.. (1997). Daleformis, a New Phytoalexin from the Roots of Dalea filiciformis:  An Inhibitor of Endothelin Converting Enzyme. Journal of Natural Products. 60(3). 306–308. 15 indexed citations
4.
DAINES, R. A., Kelvin Sham, William D. Kingsbury, et al.. (1997). Quinine analogs as non-peptide calcitonin gene-related peptide (CGRP) receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 7(20). 2673–2676. 15 indexed citations
5.
Patil, Ashok D., Alan J. Freyer, Lew Killmer, Ann Breen, & Randall K. Johnson. (1997). A New Cycloartanol Sulfate from the Green AlgaTuemoyaSp.: An Inhibitor of VZV Protease. Natural product letters. 9(3). 209–215. 4 indexed citations
6.
Patil, Ashok D., Alan J. Freyer, Ann Breen, Brad Carté, & Randall K. Johnson. (1996). Halistanol Disulfate B, a Novel Sulfated Sterol from the Sponge Pachastrella sp.:  Inhibitor of Endothelin Converting Enzyme. Journal of Natural Products. 59(6). 606–608. 15 indexed citations
8.
Patil, Ashok D., Alan J. Freyer, Drake S. Eggleston, et al.. (1993). The inophyllums, novel inhibitors of HIV-1 reverse transcriptase isolated from the Malaysian tree, Calophyllum inophyllum Linn. Journal of Medicinal Chemistry. 36(26). 4131–4138. 339 indexed citations
9.
Breen, Ann, et al.. (1993). Waterfronts: Cities Reclaim Their Edge. Medical Entomology and Zoology. 58 indexed citations
10.
Jarvest, Richard L., Ann Breen, C. Edge, et al.. (1993). Structure-directed discovery of an inhibitor of the binding of HIV GP120 to the CD4 receptor. Bioorganic & Medicinal Chemistry Letters. 3(12). 2851–2856. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026